Gerald Chan

Director at Neutrolis.

Raised on Neutrolis filings

$4.5M

of $11M offered across 2 Form D filings

Form D filings: 2
Teammates: 4
Last filing: Jul 15, 2025

Company

Biotech · Cambridge, MA

Enzymes that clear neutrophil traps in autoimmune disease

Enzymes that clear neutrophil traps in autoimmune disease

Investors: 9
Still open: $6.5M

Investors: 9
Sector: Biotech
HQ: Cambridge, MA

Neutrolis filings

Neutrolis Form D filings
Filed	Security	Sold of offered	Filing
Jul 15, 2025	Security to be acquired	$3.5M/ $10M	Form D
Apr 8, 2025	Equity	$965K/ $1M	Form D

Security to be acquiredFiled Jul 15, 2025Form D
$3.5M/ $10M
EquityFiled Apr 8, 2025Form D
$965K/ $1M

Works with

Also named on Neutrolis filings

Toby FoxMr. Fox is also the Co-Founder, Co-President and Secretary of the Issuer., Form D signerForm D signer Anthony AiudiChief Executive Officer of the Issuer, Form D signerForm D signer John SundyDirector Abdul Hakkim RahamathullahMr. Rahamathullah is also the Co-Founder, Co-President and Treasurer of the Issuer.